COLGATE PALMOLIVE CO

Three Months

Worldwide Net sales were $5,058 in the second quarter of 2024, up 4.9% from the second quarter of 2023, due to volume growth of 4.7% and net selling price increases of 4.2%, partially offset by negative foreign exchange of 4.1%. Organic sales (Net sales excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, increased 9.0% in the second quarter of 2024. A reconciliation of net sales growth to organic sales growth is provided under “Non-GAAP Financial Measures” below.

Net sales in the Oral, Personal and Home Care product segment were $3,944 in the second quarter of 2024, up 4.7% from the second quarter of 2023, due to volume growth of 5.4% and net selling price increases of 4.4%, partially offset by negative foreign exchange of 5.0%. Organic sales in the Oral, Personal and Home Care product segment increased 9.8% in the second quarter of 2024.

The Company’s share of the global toothpaste market was 41.5% on a year-to-date basis, up 0.9 share points from the year ago period, and its share of the global manual toothbrush market was 32.2% on a year-to-date basis, up 1.0 share points from the year ago period. Year-to-date market shares in toothpaste were up in Latin America, Europe and Africa/Eurasia and flat in North America and Asia/Pacific versus the comparable 2023 period. In the manual toothbrush category, year-to-date market shares were up in North America, Latin America and Asia/Pacific, flat in Europe and down in Africa/Eurasia versus the comparable 2023 period. For additional information regarding market shares, see “Market Share Information” below.

Net sales in the Hill’s Pet Nutrition segment were $1,114 in the second quarter of 2024, up 5.5% from the second quarter of 2023, due to volume growth of 2.5% and net selling price increases of 3.7%, partially offset by negative foreign exchange of 0.7%. Organic sales in the Hill’s Pet Nutrition segment increased 6.1% in the second quarter of 2024.

Gross Profit/Margin

Worldwide Gross profit increased to $3,066 in the second quarter of 2024 compared to $2,787 in the second quarter of 2023. Worldwide Gross profit in the second quarter of 2024 included charges resulting from the 2022 Global Productivity Initiative. Excluding these charges, Worldwide Gross profit increased to $3,075 in the second quarter of 2024 compared to $2,787 in the second quarter of 2023, reflecting an increase of $152 resulting from higher Gross profit margin and an increase of $136 resulting from higher Net sales.

Worldwide Gross profit margin increased to 60.6% in the second quarter of 2024 from 57.8% in the second quarter of 2023. Excluding charges resulting from the 2022 Global Productivity Initiative in the second quarter of 2024, Gross profit margin increased to 60.8% in the second quarter of 2024 from 57.8% in the second quarter of 2023. This increase in Gross profit margin was due to cost savings from the Company’s funding-the-growth initiatives (280 bps) and higher pricing (160 bps), partially offset by higher raw and packaging material costs (140 bps), which included foreign exchange transaction costs.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased 10% to $1,939 in the second quarter of 2024 compared to $1,768 in the second quarter of 2023. Selling, general and administrative expenses in both periods included charges resulting from the 2022 Global Productivity Initiative. Excluding these charges in both periods, Selling, general and administrative expenses increased 10% to $1,937 in the second quarter of 2024 compared to $1,766 in the second quarter of 2023, reflecting increased advertising investment of $105 and higher overhead expenses of $66.

Selling, general and administrative expenses as a percentage of Net sales increased by 160 bps to 38.3% in the second quarter of 2024 as compared to 36.7% in the second quarter of 2023. Excluding charges resulting from the 2022 Global Productivity Initiative in both periods, Selling, general and administrative expenses as a percentage of Net sales increased by 170 bps to 38.3% in the second quarter of 2024 as compared to 36.6% in the second quarter of 2023. This increase was primarily due to increased advertising investment (150 bps). In the second quarter of 2024, advertising investment increased as a percentage of Net sales to 14.0% from 12.5% in the second quarter of 2023, or 18% in absolute terms, to $706 as compared with $601 in the second quarter of 2023.

Other (Income) Expense, Net

Other (income) expense, net was $35 in the second quarter of 2024 and $45 in the second quarter of 2023. Other (income) expense, net in both periods included charges resulting from the 2022 Global Productivity Initiative. Excluding these charges in both periods, Other (income) expense, net was $20 in the second quarter of 2024 and $29 in the second quarter of 2023.

Operating Profit

Operating profit increased 12% to $1,092 in the second quarter of 2024 from $974 in the second quarter of 2023. Operating profit in both periods included charges resulting from the 2022 Global Productivity Initiative. Excluding these charges in both periods, Operating profit increased 13% to $1,118 in the second quarter of 2024 from $992 in the second quarter of 2023.

Operating profit margin was 21.6% in the second quarter of 2024, an increase of 140 bps compared to 20.2% in the second quarter of 2023. Excluding charges resulting from the 2022 Global Productivity Initiative in both periods, Operating profit margin was 22.1% in the second quarter of 2024, an increase of 150 bps compared to 20.6% in the second quarter of 2023. This increase in Operating profit margin was primarily due to an increase in Gross profit (300 bps), partially offset by an increase in Selling, general and administrative expenses (170 bps), both as a percentage of Net sales.

Non-Service Related Postretirement Costs

Non-service related postretirement costs were $22 in the second quarter of 2024 as compared to $29 in the second quarter of 2023. Non-service related postretirement costs in the second quarter of 2023 included charges related to the 2022 Global Productivity Initiative. Excluding these charges in the second quarter of 2023, Non-service related postretirement costs were $22 in the second quarter of 2024 and $26 in the second quarter of 2023.

Interest (Income) Expense, Net

Interest (income) expense, net was $60 in the second quarter of 2024 as compared to $58 in the second quarter of 2023.

Net Income Attributable to Colgate-Palmolive Company and Earnings Per Share

Net income attributable to Colgate-Palmolive Company in the second quarter of 2024 increased to $731 from $502 in the second quarter of 2023, and Earnings per common share on a diluted basis increased to $0.89 per share in the second quarter of 2024 from $0.60 in the second quarter of 2023. Net Income attributable to Colgate-Palmolive Company in the second quarter of 2024 included charges resulting from the 2022 Global Productivity Initiative. Net Income attributable to Colgate-Palmolive Company in the second quarter of 2023 included charges resulting from the foreign tax matter and the 2022 Global Productivity Initiative.

Excluding the items described above in both periods, as applicable, Net income attributable to Colgate-Palmolive Company in the second quarter of 2024 increased 17% to $753 from $644 in the second quarter of 2023, and Earnings per common share on a diluted basis increased 18% to $0.91 in the second quarter of 2024 from $0.77 in the second quarter of 2023.

(2)The impact of non-GAAP adjustments on diluted earnings per share may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

Net Sales and Operating Profit by Segment

Oral, Personal and Home Care

North America

Net sales in North America increased 2.5% in the second quarter of 2024 to $1,002, driven by volume growth of 5.9%, partially offset by net selling price decreases of 3.3% and negative foreign exchange of 0.1%. Organic sales in North America increased 2.5% in the second quarter of 2024. Organic sales growth was driven by the United States and Canada.

The increase in organic sales in North America in the second quarter of 2024 versus the second quarter of 2023 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste category. The increase in Personal Care was primarily due to organic sales growth in the liquid hand soap and skin health categories, partially offset by organic sales declines in the underarm protection category. The increase in Home Care was primarily due to organic sales growth in the surface cleaner category, partially offset by organic sales declines in the hand dish category.

Operating profit in North America decreased 2% in the second quarter of 2024 to $223, or 90 bps to 22.3% as a percentage of Net sales. This decrease in Operating profit as a percentage of Net sales was primarily due to an increase in Selling, general and administrative expenses (160 bps), partially offset by a decrease in Other (income) expense, net (70 bps), both as a percentage of Net sales. This increase in Selling, general and administrative expenses was primarily due to increased advertising investment (270 bps), partially offset by lower overhead expenses (90 bps). Lower overhead expenses were driven by lower logistics costs (110 bps), partially offset by higher other overhead expenses (20 bps). The decrease in Other (income) expense, net was primarily due to insurance recoveries.

Latin America

Net sales in Latin America increased 7.6% in the second quarter of 2024 to $1,267, driven by volume growth of 5.5% and net selling price increases of 13.3%, partially offset by negative foreign exchange of 11.2%. Organic sales in Latin America increased 18.8% in the second quarter of 2024. Organic sales growth was led by Argentina, Brazil and Mexico.

The increase in organic sales in Latin America in the second quarter of 2024 versus the second quarter of 2023 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories. The increase in Personal Care was primarily due to organic sales growth in the shampoo, underarm protection and bar soap categories. The increase in Home Care was primarily due to organic sales growth in the surface cleaner, fabric softener and hand dish categories.

Operating profit in Latin America increased 15% in the second quarter of 2024 to $417, or 210 bps to 32.9% as a percentage of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (350 bps), partially offset by an increase in Selling, general and administrative expenses (170 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to higher pricing and cost savings from the Company’s funding-the-growth initiatives (260 bps), partially offset by significantly higher raw and packaging material costs (380 bps), which included foreign exchange transaction costs. This increase in Selling, general and administrative expenses was due to increased advertising investment (90 bps) and higher overhead expenses (80 bps), both as a percentage of Net sales.

Europe

Net sales in Europe increased 6.2% in the second quarter of 2024 to $720, driven by volume growth of 5.2% and net selling price increases of 1.3%, partially offset by negative foreign exchange of 0.2%. Organic sales in Europe increased 6.5% in the second quarter of 2024. Organic sales growth was led by Germany, France and Poland.

The increase in organic sales in Europe in the second quarter of 2024 versus the second quarter of 2023 was primarily due to increases in Oral Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste category. The increase in Home Care was primarily due to organic sales growth in the fabric softener and hand dish categories.

Operating profit in Europe increased 19% in the second quarter of 2024 to $159, or 230 bps to 22.1% as a percentage of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (410 bps), partially offset by an increase in Selling, general and administrative expenses (150 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (250 bps), lower raw and packaging material costs (120 bps) and higher pricing. This increase in Selling, general and administrative expenses was primarily due to increased advertising investment (170 bps).

Asia Pacific

Net sales in Asia Pacific increased 2.6% in the second quarter of 2024 to $682, driven by volume growth of 3.4% and net selling price increases of 1.7%, partially offset by negative foreign exchange of 2.5%. Organic sales in Asia Pacific increased 5.1% in the second quarter of 2024. Organic sales growth was led by India and the Greater China region.

The increase in organic sales in Asia Pacific in the second quarter of 2024 versus the second quarter of 2023 was primarily due to an increase in Oral Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste category.

Operating profit in Asia Pacific increased 16% in the second quarter of 2024 to $195, or 320 bps to 28.7% as a percentage of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (370 bps) as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (310 bps) and higher pricing.

Africa/Eurasia

Net sales in Africa/Eurasia increased 2.2% in the second quarter of 2024 to $273, driven by volume growth of 8.4% and net selling price increases of 8.0%, partially offset by negative foreign exchange of 14.3%. Organic sales in Africa/Eurasia increased 16.4% in the second quarter of 2024. Organic sales growth was led by Türkiye, Nigeria and South Africa.

The increase in organic sales in Africa/Eurasia in the second quarter of 2024 versus the second quarter of 2023 was primarily due to an increase in Oral Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories.

Operating profit in Africa/Eurasia increased 4% in the second quarter of 2024 to $64, or 30 bps to 23.4% as a percentage of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (410 bps), partially offset by an increase in Selling, general and administrative expenses (390 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to higher pricing and cost savings from the Company’s funding-the-growth initiatives (210 bps), partially offset by higher raw and packaging material costs (120 bps), which included foreign exchange transaction costs. This increase in Selling, general and administrative expenses was primarily due to higher overhead expenses (330 bps) and increased advertising investment (60 bps).

Hill’s Pet Nutrition

Net sales for Hill’s Pet Nutrition increased 5.5% in the second quarter of 2024 to $1,114, driven by volume growth of 2.5% and net selling price increases of 3.7%, partially offset by negative foreign exchange of 0.7%. Organic sales in Hill’s Pet Nutrition increased 6.1% in the second quarter of 2024. Organic sales growth was led by the United States.

The increase in organic sales in the second quarter of 2024 was primarily due to organic sales growth in the therapeutic and wellness categories.

Operating profit in Hill’s Pet Nutrition increased 23% in the second quarter of 2024 to $235, or 300 bps to 21.1% as a percentage of Net sales. This increase in Operating profit as a percentage of Net sales was primarily due to an increase in Gross profit (420 bps), partially offset by an increase in Selling, general and administrative expenses (160 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (340 bps) and higher pricing, partially offset by higher raw and packaging material costs (130 bps). This increase in Selling, general and administrative expenses was primarily due to increased advertising investment (170 bps).

Corporate

Operating profit (loss) related to Corporate was $(201) in the second quarter of 2024 as compared to $(172) in the second quarter of 2023. In the second quarters of 2024 and 2023, Corporate Operating profit (loss) included charges resulting from the 2022 Global Productivity Initiative of $27 and $18, respectively.

Six Months

Worldwide Net sales were $10,124 in the first six months of 2024, up 5.5% as compared to the first six months of 2023 due to volume growth of 3.0% and net selling price increases of 6.3%, partially offset by negative foreign exchange of 3.8%. Organic sales increased 9.4% in the first six months of 2024.

Net sales in the Oral, Personal and Home Care product segment were $7,908 in the first six months of 2024, an increase of 5.8% as compared to the first six months of 2023 due to volume growth of 4.1% and net selling price increases of 6.5%, partially offset by negative foreign exchange of 4.8%. Organic sales in the Oral, Personal and Home Care product segment increased 10.6% in the first six months of 2024.

The increase in organic sales in the first six months of 2024 versus the first six months of 2023 was due to increases in Oral Care, Personal Care and Home Care organic sales. The increase in Oral Care was primarily due to organic sales growth in the toothpaste and manual toothbrush categories. The increase in Personal Care was primarily due to organic sales growth in the body wash, liquid hand soap and bar soap categories. The increase in Home Care was primarily due to organic sales growth in the surface cleaner category.

Net sales in the Hill’s Pet Nutrition segment were $2,216 in the first six months of 2024, an increase of 4.7% from the first six months of 2023 due to net selling price increases of 5.9%, partially offset by volume declines of 0.7% and negative foreign exchange of 0.5%. Organic sales in the Hill’s Pet Nutrition segment increased 5.2% in the first six months of 2024.

Net Sales and Operating Profit by Segment

Net sales and Operating profit by segment were as follows:

Net sales and Organic sales change by division were as follows:

In the first six months of 2024, Operating profit (loss) related to Corporate was $(397) as compared to $(340) in the first six months of 2023. Corporate Operating profit (loss) for the first six months of 2024 included charges resulting from the 2022 Global Productivity Initiative of $63. Corporate Operating profit (loss) for the first six months of 2023 included product recall costs of $25 and charges resulting from the 2022 Global Productivity Initiative of $23.

Gross Profit/Margin

Worldwide Gross profit increased to $6,105 in the first six months of 2024 from $5,499 in the first six months of 2023. Worldwide Gross profit in the first six months of 2024 included charges resulting from the 2022 Global Productivity Initiative. Excluding these charges, Worldwide Gross profit increased to $6,114 in the first six months of 2024 from $5,499 in the first six months of 2023, reflecting an increase of $311 resulting from higher Gross profit margin and an increase of $304 resulting from higher Net sales.

Worldwide Gross profit margin increased to 60.3% in the first six months of 2024 from 57.3% in the first six months of 2023. Excluding charges resulting from the 2022 Global Productivity Initiative in the first six months of 2024, Gross profit margin increased to 60.4% in the first six months of 2024 from 57.3% in the first six months of 2023, primarily due to cost savings from the Company’s funding-the-growth initiatives (260 bps) and higher pricing (250 bps), partially offset by higher raw and packaging material costs (210 bps).

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased 9% to $3,855 in the first six months of 2024 from $3,526 in the first six months of 2023. Selling, general and administrative expenses in both periods included charges resulting from the 2022 Global Productivity Initiative. Excluding these charges in both periods, Selling, general and administrative expenses increased to $3,852 in the first six months of 2024 from $3,524 in the first six months of 2023, reflecting increased advertising investment of $198 and higher overhead expenses of $130.

Selling, general and administrative expenses as a percentage of Net sales increased to 38.1% in the first six months of 2024 from 36.8% in the first six months of 2023. Excluding charges resulting from the 2022 Global Productivity Initiative, Selling, general and administrative expenses as a percentage of Net sales increased to 38.0% in the first six months of 2024 from 36.7% in the first six months of 2023. This increase was due to increased advertising investment (130 bps). In the first six months of 2024, advertising investment increased 17% in absolute terms to $1,378 as compared with $1,180 in the first six months of 2023, while as a percentage of Net sales it increased to 13.6% from 12.3% in the first six months of 2023.

Other (Income) Expense, Net

Other (income) expense, net was $111 in the first six months of 2024 and $90 in the first six months of 2023. Other (income) expense, net in the first six months of 2024 included charges resulting from the 2022 Global Productivity Initiative. Other (income) expense, net in the first six months of 2023 included product recall costs and charges resulting from the 2022 Global Productivity Initiative. Excluding these items in both periods as applicable, Other (income) expense, net was $60 in the first six months of 2024 and $44 in the first six months of 2023.

Operating Profit

Operating profit increased 14% to $2,139 in the first six months of 2024 from $1,883 in the first six months of 2023. Operating profit in the first six months of 2024 included charges resulting from the 2022 Global Productivity Initiative. Operating profit in the first six months of 2023 included product recall costs and charges resulting from the 2022 Global Productivity Initiative. Excluding these items in both periods as applicable, Operating profit increased to $2,202 in the first six months of 2024 from $1,931 in the first six months of 2023 due to an increase in Gross profit, partially offset by an increase in Selling, general and administrative expenses.

Operating profit margin was 21.1% in the first six months of 2024, an increase of 150 bps compared to 19.6% in the first six months of 2023. Excluding the items described above in both periods, as applicable, Operating profit margin was 21.8% in the first six months of 2024, an increase of 170 bps compared to 20.1% in the first six months of 2023, due to an increase in Gross profit (310 bps), partially offset by an increase in Selling, general and administrative expenses (130 bps), both as a percentage of Net sales.

Non-Service Related Postretirement Costs

Non-service related postretirement costs were $44 in the first six months of 2024 as compared to $323 in the first six months of 2023. Non-service related postretirement costs in the first six months of 2023 included charges related to the ERISA litigation matter and charges related to the 2022 Global Productivity Initiative. Excluding these charges in the first six months of 2024, Non-service related postretirement costs were $44 in the first six months of 2024 and $52 in the first six months of 2023.

Interest (Income) Expense, Net

Interest (income) expense, net was $118 in the first six months of 2024 as compared to $112 in the first six months of 2023.

Income Taxes

The effective income tax rate was 24.1% for the second quarter of 2024 as compared to 39.8% for the second quarter of 2023. As reflected in the table below, the non-GAAP effective income tax rate was 23.8% for the second quarter of 2024 as compared to 25.4% for the second quarter of 2023.

The effective income tax rate was 24.4% for the first six months of 2024 as compared to 34.5% for the first six months of 2023. As reflected in the table below, the non-GAAP effective income tax rate was 24.1% for the first six months of 2024 as compared to 24.9% for the first six months of 2023.

The quarterly provision for income taxes is determined based on the Company’s estimated full year effective income tax rate adjusted by the amount of tax attributable to infrequent or unusual items that are separately recognized on a discrete basis in the income tax provision in the quarter in which they occur. The Company’s current estimate of its full year effective income tax rate before discrete period items is 24.3%, compared to 24.8% in 2023.

In the third quarter of 2023, the Internal Revenue Service (the “IRS”) issued a notice giving taxpayers temporary relief from the effects of certain U.S. tax regulations that were issued in December 2021, which place greater restrictions on foreign taxes that are creditable against U.S. taxes on foreign-source income. This notice allowed taxpayers to defer the application of these new regulations through the end of 2023. In December 2023, the IRS issued further guidance modifying this temporary relief period to the date that a notice or other guidance withdrawing or modifying the temporary relief is issued. The Company will recognize the impact, if any, in the period in which the temporary relief is withdrawn or modified.

The Company has ongoing federal, state and international income tax audits in various jurisdictions and evaluates uncertain tax positions that may be challenged by local tax authorities and not fully sustained. All U.S. federal income tax returns through December 31, 2013 have been audited by the IRS and there are limited matters which the Company plans to appeal for years 2010 through 2013. One such matter relates to the IRS assessment of taxes on the Company by imputing income on certain activities within one of our international operations, which is also under audit for the years 2014 through 2018. There were U.S. Tax Court rulings during 2023 in favor of the IRS against unrelated third parties on similar matters. Despite the U.S. Tax Court rulings, the Company continues to believe that the tax assessment against the Company is without merit. While there can be no assurances, the Company believes this matter will ultimately be decided in favor of the Company. The amount of tax plus interest for the years 2010 through 2018 is estimated to be approximately $150, which is not included in the Company’s uncertain tax positions. In May 2024, the IRS initiated an audit for the years 2019 through 2021.

On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was enacted, which among other things, implements a 15% minimum tax on book income of certain large corporations effective for years beginning after December 31, 2022. Based on the Company’s analysis, as well as guidance published by the IRS, the IRA, and in particular the 15% minimum tax, did not have an impact on the Company’s Consolidated Financial Statements. The Company will continue to evaluate the potential impact of this law as additional guidance and clarification becomes available.

Additionally, on December 15, 2022, the 27 member states of the European Union (“EU”) reached an agreement on a minimum level of taxation for certain large corporations to pay a minimum corporate tax rate of 15% in every jurisdiction in which they operate. This agreement, which is known as the Minimum Tax Directive (part of the “Pillar II Model Rules”), was supposed to be transposed into the laws of all EU member states by December 31, 2023. Most member states complied while some were granted extensions of time. In addition, many other jurisdictions outside the EU have also committed to implement this Directive while others have implemented a similar minimum tax regime consistent with the policy of the Pillar II Model Rules. This Directive does not have a material impact on the Company's Consolidated Financial Statements.

During the quarter ended June 30, 2023, we reassessed with our legal and tax advisers certain tax deductions taken in prior years by one of our subsidiaries and concluded that it was more likely than not that the deductions would not be sustained by the courts in that jurisdiction. The value of the tax deductions was not material to us in any year in which they were taken. The cumulative effect of the change in tax position of $148 was reflected as a discrete item in the quarter ended June 30, 2023 income tax expense, partially offset by the reversal of certain prior years’ withholding tax reserves of $22 that were no longer required. The tax liability was paid in the quarter ended September 30, 2023.

(2)The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

Net Income Attributable to Colgate-Palmolive Company and Earnings Per Share

Net income attributable to Colgate-Palmolive Company in the first six months of 2024 increased to $1,414 from $874 in the comparable 2023 period. Earnings per common share on a diluted basis increased to $1.71 in the first six months of 2024 from $1.05 in the comparable 2023 period. Net income attributable to Colgate-Palmolive Company in the first six months of 2024 included charges resulting from the 2022 Global Productivity Initiative. Net income attributable to Colgate-Palmolive Company in the comparable 2023 period included charges resulting from the ERISA litigation matter, the foreign tax matter, the 2022 Global Productivity Initiative and product recall costs.

Excluding the items described above in both periods as applicable, Net income attributable to Colgate-Palmolive Company in the first six months of 2024 increased 17% to $1,467 from $1,252 in the first six months of 2023, and Earnings per common share on a diluted basis increased 19% to $1.78 in the first six months of 2024 from $1.50 in the first six months of 2023.

(2)The impact of non-GAAP adjustments on diluted earnings per share may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

Restructuring and Related Implementation Charges

On January 27, 2022, the Board approved the 2022 Global Productivity Initiative. Substantially all initiatives under the program have been implemented as of the second quarter of 2024 and the Company expects to incur the remaining charges in the second half of 2024. The 2022 Global Productivity Initiative resulted in the reallocation of resources towards the Company’s strategic priorities and faster growth businesses, efficiencies in the Company’s operations and the streamlining of its supply chain to reduce structural costs.

Total pretax charges from the implementation of the 2022 Global Productivity Initiative are now expected to be approximately $225 ($180 aftertax), once all the charges are recorded, which is now estimated to be comprised of the following categories: employee-related costs, including severance, pension and other termination benefits (80%); asset-related costs, primarily accelerated depreciation and asset write-downs (5%); and other charges (15%), which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities and the implementation of new strategies. It is now estimated that approximately 80% of the charges will result in cash expenditures.

Total annualized pretax savings from the 2022 Global Productivity Initiative are now expected to be approximately $125 ($100 aftertax). Savings achieved since the implementation of the 2022 Global Productivity Initiative were approximately $110 pretax ($90 aftertax).

It is now expected that the cumulative pretax charges, once all charges are recorded, will relate to initiatives undertaken in North America (10%), Latin America (10%), Europe (45%), Asia Pacific (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (15%).

For the three months ended June 30, 2024, charges resulting from the 2022 Global Productivity Initiative were $27 pretax ($23 aftertax). For the three months ended June 30, 2023, charges resulting from the 2022 Global Productivity Initiative were $21 pretax ($16 aftertax).

For the six months ended June 30, 2024 and June 30, 2023, charges resulting from the 2022 Global Productivity Initiative are reflected in the income statement as follows:

Restructuring and related implementation charges are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

Total charges incurred for the 2022 Global Productivity Initiative relate to initiatives undertaken by the following reportable operating segments and Corporate:

Since the inception of the 2022 Global Productivity Initiative, the Company has incurred cumulative pretax charges of $205 ($165 aftertax) in connection with the implementation of various projects as follows:

The following table summarizes the activity for the restructuring and related implementation charges discussed above and the related accruals:

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, written severance policies, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension enhancements, which are reflected as Charges against assets within Employee-Related Costs in the preceding table, as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension liabilities. For the six months ended June 30, 2024, there were no pension enhancements included in Charges against assets within Employee-Related Costs.

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down inventories and assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Non-GAAP Financial Measures

This Quarterly Report on Form 10-Q discusses certain financial measures on both a GAAP and a non-GAAP basis. The Company uses the non-GAAP financial measures described below internally in its budgeting process, to evaluate segment and overall operating performance and as a factor in determining compensation. The Company believes that these non-GAAP financial measures are useful in evaluating the Company’s underlying business performance and trends; however, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.

Net sales growth (GAAP) and organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments) (non-GAAP) are discussed in this Quarterly Report on Form 10-Q. Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange, as well as the impact of acquisitions and divestments, as applicable. A reconciliation of organic sales growth to Net sales growth for the three and six months ended June 30, 2024 is provided below.

Gross Profit, Gross Profit margin, Selling, general and administrative expenses, Selling, General and Administrative Expenses as a Percentage of Net Sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Earnings per share on a diluted basis are discussed in this Quarterly Report on Form 10-Q both on a GAAP basis and excluding, as applicable, charges resulting from the ERISA litigation matter, the 2022 Global Productivity Initiative, product recall costs and the foreign tax matter. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. A reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measures for the three and six months ended June 30, 2024 and 2023 is presented within the applicable section of Results of Operations.

The following tables provide a quantitative reconciliation of Net sales growth to organic sales growth for the three and six months ended June 30, 2024:

Liquidity and Capital Resources

The Company expects cash flow from operations and debt issuances will be sufficient to meet foreseeable business operating and recurring cash needs (including for debt service, dividends, capital expenditures, share repurchases and acquisitions). The Company believes its strong cash generation and financial position should continue to allow it broad access to global credit and capital markets.

Cash Flow

Net cash provided by operations increased 15% to $1,671 in the first six months of 2024, compared to $1,457 in the first six months of 2023, primarily due to higher net income, partially offset by an increase in receivables. The Company’s working capital was (2.5%) as a percentage of Net sales as of June 30, 2024 as compared to (1.3%) as of June 30, 2023. The Company defines working capital as the difference between current assets (excluding Cash and cash equivalents and marketable securities, the latter of which is reported in Other current assets) and current liabilities (excluding short-term debt).

Investing activities used $304 of cash in the first six months of 2024, compared to $438 in the first six months of 2023.

Capital expenditures were $243 in the first six months of 2024 compared to $347 in the first six months of 2023. Capital expenditures for 2024 are expected to be approximately 3.0% of Net sales. The Company continues to focus its capital spending on projects that are expected to yield high aftertax returns.

Financing activities used $1,206 of cash during the first six months of 2024, compared to $955 used in the first six months of 2023. The increase in cash used was primarily due to higher share repurchases, partially offset by higher proceeds from the exercise of stock options.

Long-term debt, including the current portion, decreased to $8,167 as of June 30, 2024, as compared to $8,239 as of December 31, 2023 and total debt was $8,676 as of June 30, 2024, as compared to $8,549 as of December 31, 2023. During the first quarter of 2024, the Company redeemed at maturity $500 of ten-year Medium-Term Notes with a fixed coupon of 3.25%. The redemption was financed with commercial paper borrowings.

Domestic and foreign commercial paper outstanding was $1,607 and $906 as of June 30, 2024 and December 31, 2023, respectively. The average daily balances outstanding for commercial paper in the first six months of 2024 and 2023 were $1,688 and $1,915, respectively. The Company classifies commercial paper and certain current maturities of notes payable as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis, including, if necessary, by utilizing its unused lines of credit or by issuing long-term debt pursuant to an effective shelf registration statement.

Certain of the agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote. Refer to Note 6, Long Term Debt and Credit Facilities to the Consolidated Financial Statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 for further information about the Company’s long-term debt and credit facilities.

In the first quarter of 2024, the Company increased the quarterly common stock dividend to $0.50 per share from $0.48 per share previously, effective in the second quarter of 2024.

Cash and cash equivalents increased $144 during the first six months of 2024 to $1,110 at June 30, 2024, compared to $966 at December 31, 2023, the majority of which ($1,016 and $922, respectively) was held by the Company’s foreign subsidiaries.

For additional information regarding liquidity and capital resources, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

Goodwill and Intangible Assets

As of the date of the annual goodwill and indefinite-lived impairment test, the fair value of the Filorga reporting unit and one of the Company’s indefinite-lived trademarks continue to approximate their carrying value.

Given the inherent uncertainties of estimating the future cash flows, the impact of interest rates and inflation on macroeconomic conditions, actual results may differ from management's current estimates which could potentially result in impairment charges in future periods.

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this Quarterly Report on Form 10-Q are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce or certain discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors we use to provide data are reliable, but we have not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information calculated by the Company may be different from market share information calculated by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This Quarterly Report on Form 10-Q may contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995 or by the SEC in its rules, regulations and releases that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, the impact of foreign exchange, the impact of geopolitical conflicts and tensions, such as the war in Ukraine, the Israel-Hamas war and tensions between China and Taiwan, cost-reduction plans (including the 2022 Global Productivity Initiative), tax rates, interest rates, new product introductions, digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of those statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Actual events or results may differ materially because of factors that affect international businesses and global economic conditions, as well as matters specific to the Company and the markets it serves, including the uncertain macroeconomic and political environment in different countries, including as a result of inflation and rising interest rates, and its effect on consumer confidence and spending, foreign currency rate fluctuations, exchange controls, import restrictions, tariffs, sanctions, price or profit controls, labor relations, changes in foreign or domestic laws, or regulations or their interpretation, political and fiscal developments, including changes in trade, tax and immigration policies, increased competition and evolving competitive practices (including from the growth of eCommerce and the entry of new competitors and business models), the ability to operate and respond effectively during a pandemic, epidemic or widespread public health concern, the ability to manage disruptions in our global supply chain and/or key office facilities, the ability to manage the availability and cost of raw and packaging materials and logistics costs, the ability to maintain or increase selling prices as needed, changes in the policies of retail trade customers, the emergence of alternative retail channels, the growth of eCommerce and the rapidly changing retail landscape (as consumers increasingly shop online and through mobile applications), the ability to develop innovative new products, the ability to continue lowering costs and operate in an agile manner, the ability to maintain the security of our information and operational technology systems from a cybersecurity incident or data breach, the ability to address the effects of climate change and achieve our sustainability and social impact goals, the ability to complete acquisitions and divestitures as planned, the ability to successfully integrate acquired businesses, the ability to attract and retain key employees and integrate DE&I initiatives across our organization, the uncertainty of the outcome of legal proceedings, whether or not the Company believes they have merit, and the ability to address uncertain or unfavorable global economic conditions, including inflation, disruptions in the credit markets and tax matters. For information about these and other factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking

Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent filings with the SEC).